L. Sawadogo

Multidrug-Resistant Tuberculosis in Burkina Faso from 2006 to 2017: Results of National Surveys

A. Diallo, L. Sangaré, G. Badoum, 2019, European journal of microbiology & immunology.

Occurrence of mutations associated with rifampicin and isoniazid resistant in Mycobacterium tuberculosis isolates from patients in Burkina Faso

A. Diallo, L. Sangaré, F. Ouédraogo, 2019, International Journal of Molecular Biology.

Risk factors for multidrug-resistant tuberculosis in four centers in Burkina Faso, West Africa.

A. S. Traoré, L. Sangaré, S. Kouanda, 2009, Microbial drug resistance.

Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.

A. S. Traoré, L. Sangaré, S. Kouanda, 2010, Annals of African medicine.

Magnitude and associated factors of latent tuberculosis infection due to Mycobacterium tuberculosis complex among high-risk groups in urban Bobo-Dioulasso, Burkina Faso

J. Zinsstag, M. Perreau, S. Diagbouga, 2022, IJID Regions.

Is deployement of diagnostic test alone enough? Comprehensive package of interventions to strengthen TB laboratory network: three years of experience in Burkina Faso

D. Cirillo, E. Tagliani, R. Alagna, 2020, BMC Infectious Diseases.

What Tool for Diagnosis of Latent Tuberculosis Infection in Developing Country with Tuberculosis High Burden: Interferon Gamma Release Assays versus Tuberculin Skin Test in Burkina Faso

B. Bonfoh, K. Addo, G. Mensah, 2022, Advances in Infectious Diseases.

Immunological and Haematological Relevance of Helminths and Mycobacterium tuberculosis Complex Coinfection among Newly Diagnosed Pulmonary Tuberculosis Patients from Bobo-Dioulasso, Burkina Faso

B. Bonfoh, K. Addo, G. Mensah, 2024, Biomedicines.